These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35046043)

  • 1. Molecular basis of differential receptor usage for naturally occurring CD55-binding and -nonbinding coxsackievirus B3 strains.
    Wang Q; Yang Q; Liu C; Wang G; Song H; Shang G; Peng R; Qu X; Liu S; Cui Y; Wang P; Xu W; Zhao X; Qi J; Yang M; Gao GF
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35046043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of decay-accelerating factor with coxsackievirus B3.
    Hafenstein S; Bowman VD; Chipman PR; Bator Kelly CM; Lin F; Medof ME; Rossmann MG
    J Virol; 2007 Dec; 81(23):12927-35. PubMed ID: 17804498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.
    Yoder JD; Cifuente JO; Pan J; Bergelson JM; Hafenstein S
    J Virol; 2012 Dec; 86(23):12571-81. PubMed ID: 22973031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.
    Carson SD; Chapman NM; Hafenstein S; Tracy S
    J Virol; 2011 Apr; 85(7):3306-14. PubMed ID: 21270163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.
    Pan J; Zhang L; Organtini LJ; Hafenstein S; Bergelson JM
    J Virol; 2015 Jan; 89(2):1324-8. PubMed ID: 25392210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
    Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
    J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells.
    Patel KP; Coyne CB; Bergelson JM
    J Virol; 2009 Nov; 83(21):11064-77. PubMed ID: 19710132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.
    Spiller OB; Goodfellow IG; Evans DJ; Hinchliffe SJ; Morgan BP
    J Gen Virol; 2002 Jan; 83(Pt 1):45-52. PubMed ID: 11752699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human astrocytic cells support persistent coxsackievirus B3 infection.
    Zhang X; Zheng Z; Shu B; Liu X; Zhang Z; Liu Y; Bai B; Hu Q; Mao P; Wang H
    J Virol; 2013 Nov; 87(22):12407-21. PubMed ID: 24027313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic and structural analysis of coxsackievirus B3 receptor interactions and formation of the A-particle.
    Organtini LJ; Makhov AM; Conway JF; Hafenstein S; Carson SD
    J Virol; 2014 May; 88(10):5755-65. PubMed ID: 24623425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
    Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
    Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.
    Pasch A; Küpper JH; Wolde A; Kandolf R; Selinka HC
    J Gen Virol; 1999 Dec; 80 ( Pt 12)():3153-3158. PubMed ID: 10567646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression.
    Böhnke J; Pinkert S; Schmidt M; Binder H; Bilz NC; Jung M; Reibetanz U; Beling A; Rujescu D; Claus C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of decay-accelerating factor with echovirus 7.
    Plevka P; Hafenstein S; Harris KG; Cifuente JO; Zhang Y; Bowman VD; Chipman PR; Bator CM; Lin F; Medof ME; Rossmann MG
    J Virol; 2010 Dec; 84(24):12665-74. PubMed ID: 20881044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection.
    Zautner AE; Körner U; Henke A; Badorff C; Schmidtke M
    J Virol; 2003 Sep; 77(18):10071-7. PubMed ID: 12941917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
    Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
    Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of disease in coxsackievirus B1 murine infection.
    Cifuente JO; Ferrer MF; Jaquenod de Giusti C; Song WC; Romanowski V; Hafenstein SL; Gómez RM
    J Med Virol; 2011 Sep; 83(9):1571-81. PubMed ID: 21739448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
    Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
    J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor.
    Pan J; Narayanan B; Shah S; Yoder JD; Cifuente JO; Hafenstein S; Bergelson JM
    J Virol; 2011 Jul; 85(14):7436-43. PubMed ID: 21561916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes mediate Coxsackievirus B3 transmission and expand the viral tropism.
    Fu Y; Xiong S
    PLoS Pathog; 2023 Jan; 19(1):e1011090. PubMed ID: 36634130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.